Akoya Biosciences, Inc.
AKYA
$1.15
-$0.01-0.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.35% | 24.10% | 18.45% | 36.79% | -24.90% |
| Total Depreciation and Amortization | -12.34% | -12.06% | -29.15% | -7.71% | -3.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.40% | -31.96% | -57.70% | -34.78% | 161.61% |
| Change in Net Operating Assets | 138.30% | 146.42% | 69.24% | -559.15% | -27.36% |
| Cash from Operations | 65.36% | 46.60% | 32.70% | 6.46% | -5.40% |
| Capital Expenditure | 74.81% | -75.42% | 47.84% | 88.05% | -0.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.85% | -- | -- | -- | -785.81% |
| Cash from Investing | 132.87% | 553.37% | 1,664.78% | 736.26% | -887.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.55% | -178.89% | 5.14% | 0.00% | -22.30% |
| Issuance of Common Stock | -80.56% | 128.57% | -52.94% | -99.95% | -37.93% |
| Repurchase of Common Stock | 48.32% | -- | -- | -- | -58.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -11.44% | 36.17% |
| Cash from Financing | 43.69% | -104.39% | -6.38% | -104.59% | -5.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.24% | -115.82% | 124.53% | -112.42% | -401.29% |